Method for preparing giant salamander grease

Abstract

The invention discloses a method for preparing giant salamander grease. The method comprises the following steps: (1) fat taking: taking down yellow fat from tails of slaughtered giant salamanders; (2) dicing: chopping the taken fat into a plurality of small pieces; (3) decocting: adding water, of which the amount is 10% that of the fat, into the chopped fat, and then, carrying out decocting in an iron pot with small fire; and immediately extinguishing fire for cooling when the fat pieces are shrunk and completely become dark yellow and a large number of light yellow grease flows out; (4) squeezing: squeezing the fat pieces treated in the step (3) by adopting a GY-ZY oil press; and (5) filtering: carrying out filtering by using screen cloth with the pore size of 100-mesh, thereby obtaining the giant salamander grease. Compared with the prior art, the method has the advantages that by eating the giant salamander grease prepared by the method disclosed by the invention, blood plasma of human bodies gradually becomes thin blood plasma from thick blood plasma until the blood plasma returns to a normal condition, and meanwhile, symptoms such as headache, dizziness and palpitation and tired heart caused by hyperlipidemia immediately disappear.

Description

technical field [0001] The invention relates to animal fat for treating hyperlipidemia in human body, in particular to a preparation method of giant salamander oil. Background technique [0002] Hyperlipidemia can be divided into two types: primary and secondary. Primary is related to congenital and heredity, and secondary is mostly related to metabolic disorders such as diabetes and hypertension, or related to other factors such as age, sex, season, drinking, smoking, diet, physical activity, mental stress, emotion activities etc. Usually, most patients have no obvious symptoms and abnormal signs. Many people are found to have elevated plasma lipoprotein levels when blood biochemical tests are performed for other reasons. Plasma total cholesterol concentration> 5.17mmol / L (200mg / dl) can be defined as hypercholesterolemia, plasma triacylglycerol concentration> 2.3mmol / L (200mg / dl) is hypertriglyceremia. [0003] Treatment of hyperlipidemia: general treatment includ...

AI Technical Summary

Problems solved by technology

Blood lipids fluctuate up and down repeatedly. Patients endure the side effects of lipid-lowering drugs and worry about blood lipid rise after drug withdrawal. Therefore, patients generally have poor compliance with lipid-lowering drugs. There is nothing to do to control blood lipids